Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
365.00    20.00 (5.80%)
Bid:
350.00
Ask:
380.00
Spread: 30.00 (8.571%)
Market Cap: £34.88m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

AGM Statement

30 Jul 2008 11:00

RNS Number : 1957A
Cropper(James) PLC
30 July 2008
 



Issued by Citigate Dewe Rogerson Ltd, Birmingham

Date: Wednesday, 30 July 2008

Embargoed: 11.00am

James Cropper PLC

Annual General Meeting and Trading update

30 July 2008

STATEMENT BY THE CHAIRMAN, J A CROPPER

At the AGM to be held at 10.30am today, James Cropper, Chairman, made the following statement:

"The performance of the Group in the opening quarter has been dominated by severe increases in energy costs, primarily that of gas. This has principally affected James Cropper Speciality Papers, which traded at a loss during the quarter. This underlines the difficult trading climate that currently faces this subsidiary that I signalled in the preliminary results statement.

To illustrate the challenges we face, volatility in forward gas prices over the last month has been sufficient, at its peak, to potentially reduce our results for the Group as a whole for the full year to a loss. Based upon current market projections the cost of gas consumed in the current financial year could exceed £5.5 million, compared with £2.7 million in the previous financial year.

Softwood and hardwood pulp prices have remained stable for the past 3 months at $900/tonne and $840/tonne respectively. Market forecasters suggest that a plateau has probably been reached as a consequence of the economic slow-down.

The impact of the increasing cost base will be mitigated in the second half of the year by further sales price increases and additional volume arising from reduced capacity resulting from contraction elsewhere in the industry.

As regards The Paper Mill Shop a programme of redundancies at outlet level has been completed. It is also intended to exit a small number of under performing stores as their leases expire unless it is more economic to do so earlier.

On a more positive note the rapid escalation in the cost of oil has spurred activity in the emerging fuel cell market. As a consequence Technical Fibre Products is beginning to experience an increase in demand for materials to service this market, particularly with regard to free-standing phosphoric acid units.  Investment over the coming year will continue to be focused on energy and operating efficiencies. A conclusion on the viability of on-site biomass combustion is expected by the autumn of 2008. If feasible and cost effective, combustion of biomass fuels could lead to a reduction in gas consumption of up to 20% and thus significant cost savings.

Although the current financial year will be undoubtedly challenging, I am confident that through our existing management approach, which combines profitable sales growth, product development, energy savings and efficiency improvements, the Group will emerge from the current economic downturn much stronger and more profitable."

Enquiries:

John DenmanGroup Finance Director

Keith GabrielSenior Account Manager

James Cropper PLC

Citigate Dewe Rogerson

Tel: 01539 722002 

Tel: 0121 455 8370

www.cropper.com

Mobile: 07770 788624

Andrew Kitchingman

Managing Director, Corporate Finance

Brewin Dolphin Investment Banking

Tel: 0845 270 8610

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMURVKRWNRBORR
Date   Source Headline
9th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSHalf-year Report
4th Nov 20217:00 amRNSDirectorate Change
24th Sep 20211:44 pmRNSDirector/PDMR Shareholding
9th Sep 20215:35 pmRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSGrant of Awards under Long Term Incentive Plan
5th Aug 20217:00 amRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSDirector/PDMR Shareholding
28th Jul 202111:00 amRNSAGM Statement and Trading Update
27th Jul 202110:27 amRNSDirector/PDMR Shareholding
23rd Jul 20219:52 amRNSDirector/PDMR Shareholding
23rd Jul 20217:00 amRNSUpdate for visitors to the AGM
21st Jul 20217:00 amRNSDirector/PDMR Shareholding
6th Jul 20217:46 amRNSDirector/PDMR Shareholding
1st Jul 20212:30 pmRNSHolding(s) in Company
22nd Jun 20218:36 amRNSDirectorate Change
22nd Jun 20217:00 amRNSFinal Results
29th Mar 20217:00 amRNSDirector Dealing
25th Mar 20217:00 amRNSDirector/PDMR Shareholding
15th Mar 20219:31 amRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSAcquisition
18th Dec 202011:05 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20202:06 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSHalf-year Report
5th Aug 20207:00 amRNSGrant of Awards under Long Term Incentive Plan
31st Jul 20207:00 amRNSDirector/PDMR Shareholding
30th Jul 20209:41 amRNSResult of AGM
29th Jul 20207:00 amRNSAGM Statement and Trading Update
27th Jul 20201:47 pmRNSDirector/PDMR Shareholding
27th Jul 20209:00 amRNSDirectorate Change
23rd Jun 20207:00 amRNSFinal Results
1st May 20207:00 amRNSYear end and COVID 19 trading update
24th Mar 20203:57 pmRNSCOVID 19 update
20th Feb 20209:45 amRNSDirector Dealing
14th Feb 202010:13 amRNSDirector Dealing
30th Jan 20208:55 amRNSDirector/PDMR Shareholding
24th Jan 20204:30 pmRNSDirector/PDMR Shareholding
21st Jan 20202:00 pmRNSHolding(s) in Company
13th Jan 202011:05 amRNSDirector/PDMR Shareholding
17th Dec 201912:24 pmRNSDirector/PDMR Shareholding
13th Dec 20197:00 amRNSDirectors' Dealings
29th Nov 201910:42 amRNSDirector/PDMR Shareholding
19th Nov 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
17th Sep 201911:20 amRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSDirectors' Dealings
9th Aug 20197:00 amRNSNotification of Transaction of PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.